Amazon's Choice and One Drop Partner to Expand Chronic Health Services

^{Image and thumbnail have been modified. Courtesy of PRNewsfoto/One Drop.}

Amazon’s health brand, Choice, is partnering with One Drop — a digital therapeutics developer — to provide diabetes and hypertension hardware, software and condition management support services to Amazon’s Choice customers, according to today’s announcement.

Amazon’s Choice — developed by Arcadia Group — launched in 2018 and offers medical devices for monitoring blood glucose and blood pressure.

Through the partnership, Choice devices will integrate directly with the One Drop mobile app. Customers will have access to One Drop’s diabetes, blood pressure and weight management capabilities, including artificial intelligence-powered automated decision support.

Amazon’s Choice customers can also enroll in One Drop’s expanded suite of personal coaching programs if they want to improve blood glucose levels, heart health, decrease weight or prevent the onset of diabetes.

One Drop can also be linked to Amazon’s Alexa voice technology, so people can ask Alexa questions about their daily schedule or tell Alexa to record certain health data.

“We are meeting people where they are and providing essential support when and where it is convenient for them,” said Jeff Dachis, founder and CEO of One Drop. “There are already enough barriers standing between us and good health. High cost, inconvenience and inaccessibility should not be among them.”

One Drop has previously collaborated with Fitbit and pairs fitness data with the Apple Watch.

The new partnership with Amazon's Choice is just the latest initiative focused on diabetes prevention and management.

Earlier this month, Fitbit and Solera Health partnered to reduce the risk of Type 2 diabetes by offering the wearable devices to people who use Solera to enroll in community-based or digital diabetes prevention programs.

And 23andMe announced last week that the genetic testing company will now offer a new genetic health predisposition report on Type 2 diabetes to warn people about their likelihood of developing the condition and to educate them on lifestyle changes that can delay or prevent the onset.

Get the best insights in healthcare analytics directly to your inbox.

Related

Unnecessary Testing Proves Costly for Patients With Type 2 Diabetes

Another Start-Up Advances AI's Assault on Diabetes

First-of-its-Kind AI Tool for Diabetic Retinopathy Detection Approved by FDA